Center for Researching and Rehabilitation of Hereditary Ataxia of Cuba (CIRAH), Carretera Central Km 5 1/2 Reparto: Edecio Pérez Holguin Cuba
2-11-05 to 4--11-05
General scientific program.The subjects to be dealed will be: Clinics. Epidemiology. Quantitative neurology. Treatments. Neurogenetics. Genetics Modifiers . Oxidative Stress. Apoptosis. Bioinformatic. Predictive Test. Electrofisiology. Neurorehabilitation. Transgenic Animal. Other topics in Hereditary Ataxias and other Dysfunctions of Movement. Plenary Lcetures Plenary Lecture:Neurodegenerative Diseases in the Caribbean, PhD.Francisco Lopera: Antioquia University -Colombia- Plenary Lecture:Cuban Spinocerebellar Ataxia Type 2 (SCA-2). The Highest Prevalence in the World, PhD. Luis Velázquez Pérez: Center for Researching and Rehabilitation of Hereditary Ataxias (CIRAH)-Cuba- Plenary Lecture:Neurochemicals Mechanisms of epilepsy of temporal lobe using biologicals models with kainic acid, PhD. Alfonso Alfaro Rodríguez: UNAM – Mexico-
Plenary Lecture:Role of NeuroImaging (mainly MR) in the assessment of hereditary ataxias: SCA1, SCA2 and FA, PhD. Mario Mascalchi: Italia Plenary Lecture:Technicals and physiologicals basis of transients otoacustics emisions, PhD. Alfredo Durand: UNAM –Mexico- Plenary Lecture:Identification of new genes involved in Ataxia Telangectasia, PhD. Ridha Barbouche: Pasteur Institute -Tunez - Plenary Lecture:T cell vaccine to aliviate neurologic diseases, PhD. Michal Schwartz: Weizmann Institute of Science -Israel -
Plenary Lecture:New trends on biologicals therapies of neurodegenerations:Stem Cells, Gene therapy, Neurochemicals and moleculars factors, PhD. René Drucker Collín: UNAM -Mexico- Plenary Lecture:Evaluation of Zinc administartion to SCA2 patients, PhD Luis Velázquez Pérez: CIRAH –Cuba- Plenary Lecture:CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms, PhD.Mitali Mukerji: Center for biology and integrative genomic -India- Plenary Lecture:A Novel Autosomal Dominant Spinocerebellar Ataxia (SCA22)Linked to Chromosome 1q22-24,PhD.Bing-Wen Soong: National Yang-Ming University School of Medicine, Taipei -China- Oral Presentations Oral Presentation:The Pathogenesis of Machado Joseph Disease: A High Manganese/Low Magnesium Initiated CAG Expansion Mutation in Susceptible Genotypes?, PhD.Mark Purdey:England Oral Presentation:Neurochemicals aspects linked to functional restoration, BSc. Antonio Bueno Nava:UNAM –Mexico- Oral Presentation:Neurochemicals aspects of restoration in dammaged brains, PhD.Rigoberto González Piña:UNAM –Mexico- Oral Presentation:Medical, Social and Ethicals aspects linked in human genome researching, PhD. Víctor Penchszadeh:Beth Israel College -USA- Oral Presentation:Neurophysiological characterization of Cuban SCA2, PhD Luis Velázquez:CIRAH -Cuba- Oral Presentation:Genotypical characterization of Cuban SCA2, BSc. Luis E. Almaguer Mederos:CIRAH -Cuba- Oral Presentation:Autonomical Nervous System disfunction in neurodegeneratives diseases, MD.Gilberto Sánchez: CIRAH Cuba- Oral Presentation: Cuban Prenatal and Presintomatic program in SCA2:5 year of follow up study, PhD.Milena Paneque Herrera:CIRAH -Cuba- Oral Presentation:Alterations in Saccadic Movements in Neurodegenerative diseases, PhD.Luis Velázquez: CIRAH -Cuba- Oral Presentation:Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cells neurodegeneration in transgenic mice, PhD Jorge Aguiar:CIGB -Cuba- Oral Presentation:Evoked Potentials Neurodegenerative diseases, PhD. Alfredo Durand: UNAM –Mexico- Oral Presentation:Molecular basis of polyglutamine diseases. Cellular models of SCA2, PhD. Julio Raúl Fernández Massó: CIGB -Cuba- Oral Presentation:Generation of SCA2 monoclonal antibodies, BSc. Silian Cruz:CIGB -Cuba- Oral Presentation:Technicals and physiologicals basis of auditive potentials of brain stem, PhD. Alfredo Durand: UNAM -Mexico Oral Presentation:Last results of Cuban Neurorehabilitation Program, BSc. Julio César Rodriguez: CIRAH –Cuba- Oral Presentation:IGF-1 serum levels are reduced in SCA-2 patients, BSc. Maria M. Vázquez: CIGB -Cuba- Oral Presentation:Application of bone marrow stromal cells for the treatment of neurological disorders, BSc. Yssel Mendoza: CIGB -Cuba- Poster section Anti-gliadin antibodies in Cuban SCA2 patients, BSc. Luis Almaguer Mederos:CIRAH –Cuba- Age of Onset and Genetic risk estimation in Cuban SCA2 population, BSc. Luis Almaguer Mederos:CIRAH –Cuba- Determination and evaluation of Oxidative stress markers in Cuban SCA2 patients, BSc. Dennis Almaguer Gotay:CIRAH –Cuba-
|